Hellamand, PasoonVan De Sande, MarleenØrnbjerg, Lykke MidtbøllKlausch, ThomasNurmohamed, Michael T.Van Vollenhoven, Ronald F.Nordström, DanHokkanen, Anna MariSantos, Maria JoseVieira-Sousa, ElsaLoft, Anne G.Glintborg, BenteHetland, Merete LundLindström, UlfWallman, Johan K.Michelsen, BrigitteKlami Kristianslund, EirikCiurea, AdrianNissen, Michael S.Codreanu, CatalinMogosan, CorinaMacfarlane, Gary J.Rotariu, OvidiuRotar, ZigaTomšič, MatijaCastrejon, IsabelOtero-Varela, LuciaGudbjornsson, BjornGeirsson, Arni JonVencovský, JiPavelka, KarelGulle, SemihZengin, BerrinIannone, FlorenzoFoti, RosarioOstergaard, MikkelVan Der Horst-Bruinsma, Irene2024-02-292024-02-292023-12-12Hellamand, P, Van De Sande, M, Ørnbjerg, L M, Klausch, T, Nurmohamed, M T, Van Vollenhoven, R F, Nordström, D, Hokkanen, A M, Santos, M J, Vieira-Sousa, E, Loft, A G, Glintborg, B, Hetland, M L, Lindström, U, Wallman, J K, Michelsen, B, Klami Kristianslund, E, Ciurea, A, Nissen, M S, Codreanu, C, Mogosan, C, Macfarlane, G J, Rotariu, O, Rotar, Z, Tomšič, M, Castrejon, I, Otero-Varela, L, Gudbjornsson, B, Geirsson, A J, Vencovský, J, Pavelka, K, Gulle, S, Zengin, B, Iannone, F, Foti, R, Ostergaard, M & Van Der Horst-Bruinsma, I 2023, 'Sex differences in the effectiveness of first-line tumour necrosis factor inhibitors in axial spondyloarthritis : Results from the EuroSpA Research Collaboration Network', RMD Open, vol. 9, no. 4, e003325. https://doi.org/10.1136/rmdopen-2023-0033252056-5933PubMedCentral: PMC10729105ORCID: /0000-0003-2322-3314/work/154626525https://hdl.handle.net/2164/22881141925309engankylosing spondylitisbiological therapyepidemiologyspondylitis, ankylosingtumor necrosis factor inhibitorsR Medicine (General)RheumatologyImmunology and AllergyImmunologySupplementary DataR1Journal article10.1136/rmdopen-2023-003325http://www.scopus.com/inward/record.url?scp=85180089147&partnerID=8YFLogxK94